A Case of Hemolytic Uremic Syndrome after Transarterial Chemoembolization with Cisplatin / 대한내과학회지
Korean Journal of Medicine
;
: 67-72, 2013.
Article
Dans Coréen
| WPRIM
| ID: wpr-53546
ABSTRACT
Hemolytic uremic syndrome (HUS) is a rare disorder characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. These characteristics are related to the formation of platelet-rich microthrombi in the microvasculature. HUS is associated with a variety of etiologies, including cisplatin. Previously reported HUS cases after cisplatin administration were almost always related to systemic combination chemotherapy that included cisplatin. Transarterial chemoembolization (TACE) is commonly used in treatment of hepatocellular carcinoma, and most centers in Korea use cisplatin. A 70-year-old female with hepatocellular carcinoma was treated with TACE including cisplatin and subsequently developed clinical and laboratory findings compatible with HUS.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Thrombopénie
/
Cisplatine
/
Chimioembolisation thérapeutique
/
Carcinome hépatocellulaire
/
Association de médicaments
/
Microvaisseaux
/
Atteinte rénale aigüe
/
Syndrome hémolytique et urémique
/
Anémie hémolytique
/
Corée
Limites du sujet:
Femelle
/
Humains
Pays comme sujet:
Asie
langue:
Coréen
Texte intégral:
Korean Journal of Medicine
Année:
2013
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS